trending Market Intelligence /marketintelligence/en/news-insights/trending/GWt8au9_pBTjAWexJwn4sg2 content esgSubNav
In This List

BioTime plans common stock offering

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022

Blog

Insight Weekly: CEO pay jumps; yield curve inversion deepens; wind giants lift turbine prices


BioTime plans common stock offering

BioTime Inc. plans to sell common shares in an underwritten public offering.

The company plans to grant the underwriters an overallotment option to buy up to an additional 15% of the shares offered.

BioTime plans to use the net proceeds for general corporate purposes, including, without limitation, to fund clinical trials of products it is developing, to finance its research and development programs, and for working capital.

Raymond James & Associates Inc. will act as the sole book-running manager for the offering.